PIB TrackerIndia backed the Pandemic Agreement and fenced four of its obligations
At the UN High-Level Meeting, India's ask was specific and its commitments were conditional. The WHO Director-General wanted the opposite of what India wanted.
What happened
- Union Health Secretary Punya Salila Srivastava spoke at the UN High-Level Meeting on Pandemic Prevention, Preparedness and Response, New York, 25 September.
- She called the WHO Pandemic Agreement of May 2025 a milestone whose credibility depends on a fair Pathogen Access and Benefit Sharing (PABS) system.
- Pathogen contributors must get timely access to vaccines, diagnostics, therapeutics and technologies, with national sovereignty respected.
- She asked that digital public infrastructure be recognised as a global public good, and cited 300 million doses to about 100 countries.
- WHO DG Tedros urged that PABS negotiations conclude urgently; UN Deputy Secretary-General Amina Mohammed warned against complacency.
For Prelims
- The WHO Pandemic Agreement: adopted in May 2025. Its operative annex on PABS is still being negotiated, which is why the agreement exists but does not yet bite.
- PABS: Pathogen Access and Benefit Sharing - share the pathogen sample, receive a share of what is made from it. The same bargain the Convention on Biological Diversity and its Nagoya Protocol apply to genetic resources, moved to outbreak samples.
- Why India cares: a vaccine manufacturer that is also a likely pathogen source wants both halves - sample-sharing obligations matched by product and technology entitlements.
- The IHR: the International Health Regulations, amended after COVID-19, are the binding notification-and-response framework that sits under the new Agreement.
- One Health: treating human, animal and environmental health as one system. India supported it "as appropriate, in accordance with domestic law, international law and national circumstances".
- India's stated COVID-19 outreach: 300 million vaccine doses to about 100 countries and two UN entities; medical assistance to over 150 countries; framed as "One Earth, One Health" and the Global South.
- Global public good: a good that is non-rival and non-excludable across borders. Asking that DPI be classed as one is a claim about how India's stack should be shared and financed, not merely praise for it.
- The two counter-positions at the same meeting: Tedros on concluding PABS urgently, and Amina Mohammed on community-based early detection, surveillance and communication.
For UPSC: This is the current state of global health governance in a single speech, and it is unusually quotable. Use it on international institutions and treaty-making after COVID-19, on India as a Global South actor with manufacturing leverage, on sovereignty versus multilateral obligation, and on digital public infrastructure as an instrument of foreign policy rather than only of domestic delivery.
What it is NOT: The release gives no Indian financial commitment, no figure for what domestic preparedness financing amounts to, and no numbers for the laboratory networks, stockpiles or workforce expansion it describes. It does not say what India wants the PABS annex to contain - only that the declaration should not prejudge it - so the negotiating position is stated as a procedural preference rather than a substantive one. It does not say whether India has ratified or accepted the Agreement, or where the amended International Health Regulations stand for India. And it gives no year for the 300 million doses or the 150 countries, so the flagship figure floats free of the period it describes.
For Mains
Syllabus: GS2.20 · GS2.18 · Linkage L1
Anchor
India told the UN High-Level Meeting that the WHO Pandemic Agreement is an important milestone. It then qualified its implementation four times in the same speech: the political declaration must not prejudge the PABS annex negotiations; implementation must follow national circumstances and capacities; One Health applies as appropriate and in accordance with domestic law; and reviews of preparedness tools and data must happen only in consultation with member states. The endorsement is unconditional. The obligations are not.
Substantiation (data)
The credential India brings is concrete: 300 million vaccine doses to around 100 countries and two UN entities, and medical assistance to over 150 countries during COVID-19. The domestic build-out cited covers laboratory networks, emergency coordination, health workforce, stockpiles and clinical care capacity. At the same meeting the WHO Director-General pressed for the PABS negotiations to be concluded, and the UN Deputy Secretary-General warned against post-pandemic complacency.
Position
India's core demand is the right one and it is a matter of simple reciprocity. A country that shares an outbreak sample is handing over the input to someone else's vaccine. If that transfer carries no entitlement to the product, the incentive to share early - which is the whole point of the system - collapses. Benefit sharing is not a developing-country concession sought; it is the condition under which surveillance works.
Counterpoint
Every caveat India attached also weakens the instrument it says it wants. A framework implemented "in accordance with national circumstances and capacities" is a framework each party sizes for itself, and One Health applied "as appropriate" is One Health at each state's discretion. The same sovereignty language that protects India's policy space protects the country that decides not to report an outbreak.
Problematisation
The interesting shift is in what India is offering. In 2021 the contribution was doses; here it is architecture - a request that digital public infrastructure be recognised as a global public good. That converts a domestic system into an export and a claim on international financing at the same time. It is a stronger long-term position than vaccine diplomacy, and one the release does not price, staff or commit anything to.
Conclusion
The Pandemic Agreement exists; the part that would make it work does not yet. India is arguing for the bargain that makes early sharing rational while reserving the discretion to implement at its own pace, and the WHO is arguing for speed. Whichever wins, the PABS annex is where the next pandemic response is actually being written.
Deploys into: Global health governance after COVID-19 · Benefit sharing and the Nagoya principle applied to pathogens · India as a Global South manufacturer-negotiator · DPI as foreign policy
Ministry of Health and Family Welfare · 2026-09-26 · PRID 2315210 · PIB source ↗